Model K-NK00X - NK Cells for Cancer Immunotherapeutics

Kiadis’ NK-cell program consists of off-the-shelf and haplo donor cell therapy products for the treatment of liquid and solid tumors. Our proprietary off-the-shelf NK-cell platform is based on NK-cells from a unique universal donor, expanded and activated ex vivo using our PM21 particle technology. The Kiadis off-the-shelf platform has the potential to make NK-cell therapy products rapidly and economically available for a broad patient population across a potentially wide range of indications.